Oculoplastic Update: Eyelid & Lacrimal Problems

Saturday, December 2, 2023, 8:30 AM - 12:00 PM, Wills Eye Auditorium, Philadelphia, PA


AMA PRA Category 1 Credits™ (3.50 hours), Non-Physician Attendance (3.50 hours)

Click Here to Register for the Livestream

This presentation will benefit comprehensive ophthalmologists and those practicing oculoplastics alike. It will touch upon novel and updated techniques in treating common plastics problems and teach proper management and triage of dangerous diseases that warrant proper diagnosis in the community.

1. This presentation will benefit comprehensive ophthalmologists and those practicing oculoplastics alike. It will touch upon novel and updated techniques in treating common plastics problems and teach proper management and triage of dangerous diseases that warrant proper diagnosis in the community.
2. Identify basic and clinical vision research that can be transformed into improved clinical care.
3. Assess the role of new technologies in the evaluation and treatment of eyelid and adnexal disease.
4. Identify clinical, scientific and ethical issues confronting the profession.
5. Describe factors that impact the effective delivery of the highest quality eye care for the public.

AMA PRA Statement
Wills Eye Hospital designates this Live Activity for a maximum of 3.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The registration form for this activity is currently unavailable.

Mitigation of Relevant Financial Relationships

In compliance with the Standards for Integrity and Independence in Accredited Continuing Education set by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Wills Eye Hospital that the information presented at CME activities will be commercially unbiased and based upon clinical and scientific evidence. To help participants make judgments about the presence of commercial bias, Wills Eye Hospital provides information that all individuals in a position to control the content of a CME activity (including faculty, planners, reviewers or others) have disclosed about all financial relationships they have with ineligible companies. All relevant financial relationships have been mitigated.

Ineligible companies are companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. The CME activity staff at Wills Eye Hospital report no financial relationships with ineligible companies.

Saturday, December 2, 2023